Table 4.
Strength of the instrument in subgroups defined by observed risk factors
| Variable | Instrument Strength | 95% CI |
|---|---|---|
| U* |
E[X|U* = 1, Z = 1] − E[X|U* = 1, Z = 0] |
|
| Patient Characteristics | ||
| Full Population | 22.8% | 21.8 – 23.8% |
| Female Gender | 22.1% | 23.6 – 28.8% |
| Age ≥ 75 | 23.1% | 21.9 – 24.2% |
| History of GI Bleed | 18.2% | 10.3 – 26.2% |
| History of Peptic Ulcer Disease | 18.9% | 13.5 – 24.3% |
| History of Coronary Procedure or Hospitalization | 22.6% | 20.0 – 20.5% |
| Recent/Concomitant Medications | ||
| Concomitant Use of a GI Protective Drugs | 18.7% | 14.1 – 23.2% |
| History of GI Protective Drug Use | 20.1% | 18.1 – 22.0% |
| Recent Use of Glucocorticoids | 19.7% | 16.2 – 23.2% |
| Recent Use of Warfarin | 14.9% | 12.1 – 17.7% |